GLOBAL RESEARCH ARCHIVE
Trading at a discount
Research evidence excerpt
Trading at a discount
le to select stocks in Asia/Australia/NZ
12-month target – Expected share price *equivalent fully paid ordinary weighted average number of
in 12 months Note: expected return is reflective of a Medium Volatility shares
Valuation – The company's estimated stock and should be assumed to adjust proportionately
All Reported numbers for Australian/NZ listed stocks are fair value share price based on the disclosed with volatility risk
modelled under IFRS (International Financial Reporting valuation methodology
Standards). Note: Quant recommendations may differ
from Fundamental Analyst recommendations
Recommendation proportions for quarter ending 30 Jun 2026
AU/NZ Asia USA
Outperform 65.38% 70.02% 64.29% (for global coverage by Macquarie, 1.91% of stocks followed are investment banking clients)
Neutral 27.62% 16.78% 35.71% (for global coverage by Macquarie, 0.40% of stocks followed are investment banking clients)
Underperform 6.99% 13.19% 0.00% (for global coverage by Macquarie, 0.00% of stocks followed are investment banking clients)
Company-Specific Disclosures
Company Name Disclosure
Alpha HPA (A4N AU) Macquarie managed or co-managed a public offering of securities of Alpha HPA Ltd in the past 12 months, for which it received
Outperform compensation.
12-month target: AUD1.05 - DCF/ Macquarie Group Limited together with its affiliates owns a net long of 0.5% or more of the equity securities of Alpha HPA Ltd.
multiples A Macquarie analyst(s) involved with the preparation of this research has, in the past 12 months, visited material operations of
Valuation: AUD 0.96 - DCF (WACC Alpha HPA Ltd. In connection with such a visit, the company may have furnished local transportation and/or accommodation,
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer